| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
AURA
Aura Biosciences Inc
|
Jun 02, 2026 | BUY |
Strong Buy
+238.0% avg upside
9 analysts
|
— | -7.1% |
|
DMRA
Damora Therapeutics
|
May 15, 2026 | BUY |
Strong Buy
+26.5% avg upside
19 analysts
|
$51.00
138.14% Upside
|
· |
|
IMNM
Immunome
|
May 15, 2026 | BUY |
Strong Buy
+85.6% avg upside
16 analysts
|
$33.00
78.13% Upside
|
-11.2% |
|
TNGX
Tango Therapeutics
|
May 15, 2026 | BUY |
Strong Buy
+11.8% avg upside
14 analysts
|
$55.00
70.26% Upside
|
+60.0% |
|
STRO
Sutro Biopharma
|
May 15, 2026 | BUY |
Strong Buy
+37.1% avg upside
20 analysts
|
$43.00
51.35% Upside
|
-26.1% |
|
CMPX
Compass Therapeutics
|
Apr 27, 2026 | BUY |
Strong Buy
+367.3% avg upside
19 analysts
|
$11.00
436.68% Upside
|
+1.1% |
|
ANL
Adlai Nortye Ltd. Sponsored ADR
|
Mar 20, 2026 | BUY |
Strong Buy
+111.6% avg upside
6 analysts
|
$23.00
124.23% Upside
|
+82.6% |
|
BBOT
BridgeBio Oncology Therapeutics
|
Mar 06, 2026 | BUY |
Strong Buy
+227.0% avg upside
10 analysts
|
$41.00
433.91% Upside
|
-26.3% |
|
RLMD
Relmada Therapeutics
|
Jan 23, 2026 | BUY |
Buy
+109.9% avg upside
15 analysts
|
$8.00
21.23% Upside
|
+63.5% |
|
AGIO
Agios Pharma
|
Dec 25, 2025 | BUY |
Strong Buy
+78.4% avg upside
29 analysts
|
$40.00
20.90% Upside
|
+0.5% |
|
ZYME
Zymeworks
|
Nov 19, 2025 | BUY |
Strong Buy
+39.8% avg upside
25 analysts
|
$40.00
72.93% Upside
|
-0.5% |
|
NUVL
Nuvalent
|
Nov 17, 2025 | BUY |
Buy
-0.2% avg upside
21 analysts
|
$149.00
20.71% Upside
|
+14.2% |
|
CELC
Celcuity
|
Nov 17, 2025 | BUY |
Strong Buy
+41.4% avg upside
16 analysts
|
$97.00
10.14% Upside
|
-4.5% |
|
COGT
Cogent Biosciences
|
Nov 10, 2025 | BUY |
Strong Buy
+9.2% avg upside
26 analysts
|
$50.00
48.44% Upside
|
+5.5% |
|
IMRX
Immuneering
|
Oct 31, 2025 | BUY |
Strong Buy
+305.9% avg upside
10 analysts
|
$15.00
240.13% Upside
|
-24.9% |
|
EXEL
Exelixis
|
Oct 21, 2025 | BUY |
Strong Buy
-21.4% avg upside
33 analysts
|
$48.00
8.41% Downside
|
+47.0% |
|
IDYA
IDEAYA Biosciences
|
Oct 21, 2025 | HOLD |
Strong Buy
+55.3% avg upside
29 analysts
|
$33.00
5.47% Upside
|
+4.2% |
|
CGEM
Cullinan Management
|
Sep 04, 2025 | BUY |
Strong Buy
+132.3% avg upside
15 analysts
|
— | +98.3% |
|
OKUR
OnKure Therapeutics
|
Aug 13, 2025 | BUY |
Buy
+453.1% avg upside
12 analysts
|
$33.00
669.18% Upside
|
+28.3% |
|
RLAY
Relay Therapeutics
|
Aug 12, 2025 | BUY |
Strong Buy
+28.3% avg upside
19 analysts
|
$12.00
22.94% Downside
|
+373.1% |
|
BOLD
Boundless Bio Inc.
|
Aug 11, 2025 | HOLD |
Buy
+542.9% avg upside
11 analysts
|
$3.00
114.32% Upside
|
+30.6% |
|
ONC
BeOne Medicines
|
Aug 07, 2025 | BUY |
Strong Buy
+31.0% avg upside
28 analysts
|
$345.00
31.43% Upside
|
-11.9% |
|
ZNTL
Zentalis Pharmaceuticals
|
Aug 07, 2025 | HOLD |
Buy
+300.1% avg upside
16 analysts
|
$5.00
38.21% Upside
|
+146.9% |
|
ARVN
Arvinas Holding Company
|
Aug 07, 2025 | HOLD |
Buy
+266.4% avg upside
27 analysts
|
$9.00
17.28% Upside
|
+21.5% |
|
HK:2256
Abbisko Cayman Limited
|
Aug 05, 2025 | BUY |
Strong Buy
+150.8% avg upside
3 analysts
|
$18.00
101.03% Upside
|
· |
|
INCY
Incyte
|
Jul 30, 2025 | BUY |
Buy
+1.0% avg upside
47 analysts
|
$103.00
4.07% Upside
|
+27.7% |
|
GH
Guardant Health
|
Feb 26, 2025 | BUY |
Strong Buy
-5.0% avg upside
30 analysts
|
— | +126.8% |
|
ASH
Ashland
|
Dec 10, 2024 | BUY |
Strong Buy
+12.1% avg upside
16 analysts
|
— | -18.7% |
|
CCCC
C4 Therapeutics
|
Feb 07, 2023 | BUY |
Strong Buy
+354.5% avg upside
19 analysts
|
$25.00
537.66% Upside
|
-12.7% |
|
GLUE
Monte Rosa Therapeutics
|
Feb 07, 2023 | HOLD |
Strong Buy
+27.2% avg upside
14 analysts
|
$15.00
18.52% Downside
|
-40.0% |
|
SVRN
OceanPal Inc
|
Mar 21, 2022 | BUY |
Strong Buy
6 analysts
|
— | · |
|
PBYI
Puma Biotechnology
|
May 07, 2021 | HOLD |
Buy
+480.9% avg upside
11 analysts
|
$10.00
38.28% Upside
|
-79.7% |
|
NBRVF
Nabriva Therapeutics
|
Jan 17, 2018 | BUY |
Buy
+13374900.0% avg upside
9 analysts
|
$10.00
9999900.08% Upside
|
· |
|
RYTM
Rhythm Pharmaceuticals
|
Nov 01, 2017 | HOLD |
Strong Buy
+26.0% avg upside
19 analysts
|
$23.00
76.05% Downside
|
+10.7% |
|
OCUL
Ocular Therapeutix
|
Jul 14, 2017 | HOLD |
Strong Buy
+153.7% avg upside
21 analysts
|
$8.00
17.09% Downside
|
+3.6% |
|
RMTI
Rockwell Med
|
Jul 18, 2016 | SELL |
Buy
+1422.7% avg upside
11 analysts
|
— | +6.0% |
|
AKBA
Akebia Therapeutics
|
Jul 18, 2016 | BUY |
Strong Buy
+864.1% avg upside
16 analysts
|
— | +61.2% |
|
CG
Carlyle Group
|
Feb 17, 2016 | BUY |
Buy
+23.2% avg upside
25 analysts
|
$20.00
56.20% Downside
|
+24.3% |
|
ENTA
Enanta Pharmaceuticals
|
Dec 01, 2014 | HOLD |
Buy
+160.1% avg upside
17 analysts
|
— | -28.3% |
|
GILD
Gilead Sciences
|
Dec 01, 2014 | HOLD |
Strong Buy
-5.7% avg upside
66 analysts
|
— | +6.1% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.